These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28939141)

  • 1. Anaphylactic shock to H1 antihistamine drug bilastine: A case report.
    Coattrenec Y; Spoerl D; Jandus P; Harr T
    J Allergy Clin Immunol Pract; 2018; 6(1):256-257. PubMed ID: 28939141
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with anaphylaxis to diphenhydramine without cross-reactivity to loratadine.
    Au EYL; Rosa Duque JS; Lau CS; Chan E
    J Allergy Clin Immunol Pract; 2018; 6(3):1061-1063. PubMed ID: 29196087
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-induced anaphylaxis with positive skin test results.
    Rodriguez-Nava G; Kesler AM; Carrillo-Martin I; Gonzalez-Estrada A
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):654-655. PubMed ID: 30926309
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock).
    Limsuwan T; Demoly P
    Med Clin North Am; 2010 Jul; 94(4):691-710, x. PubMed ID: 20609858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Sologuren A; Viñas R; Cordón E; Riesgo SE; Del Mar Forés M; Senán MR; Fernández S; Labeaga L; Ruiz-Miján M
    Allergy Asthma Proc; 2018 Jul; 39(4):299-304. PubMed ID: 29559031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M; Yagami A; Togawa M; Saito A; Furue M
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.
    Church MK
    Expert Opin Drug Saf; 2011 Sep; 10(5):779-93. PubMed ID: 21831011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilastine: a lifetime companion for the treatment of allergies.
    Church MK; Tiongco-Recto M; Ridolo E; Novák Z
    Curr Med Res Opin; 2020 Mar; 36(3):445-454. PubMed ID: 31612732
    [No Abstract]   [Full Text] [Related]  

  • 11. The CD45dim/CD123bright/HLADRneg BAT in the Anti-histamine Drug Allergy.
    Chirumbolo S; Bjorklund G
    Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):203-205. PubMed ID: 32372634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focusing into new challenges in allergic rhinitis and urticaria. Introduction.
    Valero Santiago AL
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():1. PubMed ID: 22185043
    [No Abstract]   [Full Text] [Related]  

  • 13. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Reaction to Omalizumab in Patients with Chronic Urticaria: Flare Up or Ineffectiveness?
    Ertaş R; Özyurt K; Yıldız S; Ulaş Y; Turasan A; Avcı A
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):82-6. PubMed ID: 26996116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
    Soter NA
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
    Kurz K
    Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis and urticaria.
    Williams KW; Sharma HP
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):199-219. PubMed ID: 25459585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.